首页 | 本学科首页   官方微博 | 高级检索  
     

胰腺癌中CIP2A与p-Akt、N-cadherin、MMP-9的表达及其临床意义
引用本文:付京东,;薛栋,;常刚,;李新军,;张同军,;巩本刚. 胰腺癌中CIP2A与p-Akt、N-cadherin、MMP-9的表达及其临床意义[J]. 中国现代普通外科进展, 2014, 0(10): 779-783
作者姓名:付京东,  薛栋,  常刚,  李新军,  张同军,  巩本刚
作者单位:[1]山东省博兴县人民医院外一科,山东滨州256500; [2]滨州市人民医院肝胆外科,山东滨州256610; [3]滨州市人民医院外周介入科,山东滨州256610; [4]滨州市人民医院病理科,山东滨州256610
摘    要:目的:探讨胰腺癌组织中蛋白磷酸酶2A癌性抑制因子(CIP2A)、p-Akt、N-cadherin及MMP-9蛋白的表达及其临床意义。方法:采用免疫组织化学法检测42例胰腺癌及癌旁组织中CIP2A、p-Akt、N-cadherin和MMP-9的表达情况,分析其与临床病理因素的关系。结果:CIP2A在胰腺癌及癌旁组织中的表达率分别为71.4%、7.7%,差异有统计学意义(P0.05);p-Akt在胰腺癌及癌旁组织中的表达率分别为66.7%、11.5%,差异有统计学意义(P0.05)。N-cadherin在胰腺癌及癌旁组织中的表达率分别为59.5%、7.7%,差异有统计学意义(P0.05)。MMP-9在胰腺癌组织及癌旁组织中的表达率分别为61.9%、15.4%,差异有统计学意义(P0.05)。CIP2A、p-Akt在胰腺癌组织中的表达与分化程度、TNM分期、淋巴结转移明显相关(均P0.05),N-cadherin、MMP-9在胰腺癌组织中的表达与分化程度、TNM分期、神经浸润、淋巴结转移明显相关(P0.05)。胰腺癌组织中,CIP2A和p-Akt、N-cadherin和MMP-9的表达均呈正相关(均P0.05);p-Akt与N-cadherin及MMP-9的表达均呈正相关(P0.05);N-cadherin与MMP-9的表达呈正相关(P0.05)。结论:CIP2A参与了胰腺癌恶性进展,可能通过PI3K/Akt信号通路诱导上皮间质转化,促进胰腺癌增殖、侵袭和转移。CIP2A有望成为治疗胰腺癌的一个靶向治疗基因。

关 键 词:胰腺肿瘤  蛋白磷酸酶2A癌性抑制因子  p-蛋白激酶B  N-钙黏素  基质金属蛋白酶-9  上皮间质转化

Expression and signifance of CIP2A,p-Akt,N-cadherin and MMP-9 in pancreatic carcinoma
Affiliation:FU Jing-dong,XUE Dong,CHANG Gang,LI Xin-jun,ZHANG Tong-jun,GONG Ben-gang(1.Department of Surgery One, the People's Hospital of Boxing Binzhou 256500, China;2.Department of Hepatobiliary Surgery of the People's Hospital of Binzhou City Binzhou 256610, China;3.Department of Peripheral Intervention of the People's Hospital of Binzhou City Binzhou 256610, China;4.Department of Pathology of the People's Hospital of Binzhou City Binzhou 256610, China)
Abstract:Objective:To study the expressions of ClP2A,p-Akt,N-cadherin and MMP-9 in pancreatic carcinoma and their clinical significance.Methods:The expressions of CIP2A,p-Akt,N-cadherin and MMP-9 proteins were tested by immunohistochemistry in 42 cases of pancreatic carcinomas and adjacent paracancerous tissues.Results:The positive rate of CIP2A in pancreatic carcinomas was significantly higher than adjacent paracancerous tissues (71.4% vs 7.7%,P<0.05).Significant differences were also observed in the expression rate of p-Akt between the patients with pancreatic carcinomas and paracancerous tissues (66.7% vs 11.5%,P<0.05).The positive rate of N-cadherin in pancreatic carcinomas and paracancerous tissues (59.5% vs 7.7%,P<0.05).Significant differences were also observed in the expression rate of MMP-9 between pancreatic carcinomas and paracancerous tissues (61.9% vs 15.4%,P<0.05).The differences of the expression of CIP2A and p-Akt in pancreatic carcinoma of tumor differentiation,TNM stage and lymph node metastasis were significant (all P<0.05).The differences of the expression of N-cadherin and MMP-9 in pancreatic carcinoma of tumor differentiation,TNM stage,neural invasion and lymph node metastasis were also significant (all P<0.05).Significantly positive correlation was found between the expression of ClP2A and the others (p-Akt,N-cadherin and MMP-9) by using spearman correlation analysis (all P<0.05).Significantly positive correlation was found between the expression of p-Akt and the others (N-cadherin and MMP-9) by using spearman correlation analysis(all P<0.05).Significantly positive correlation was found between the expression of N-cadherin and MMP-9 by using spearman correlation analysis (P<0.05).Conclusion:CIP2A was involved in the development of pancreatic carcinoma and may promote EMT through the PI3K/Akt pathway.The data identified CIP2A as a critical oncoprotein involved in cell proliferation,invasion and metastasis,which coul
Keywords:Pancreatic carcinoma  Cancerous inhibitor of protein phosphatase2A  p-Akt  N-cadherin  MMP-9  Epithelial-mesenchymal Transition
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号